Manganese Sulfate Anhydrous

CHEMBL1200557 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
151.0 g/mol
LogP
Phase
4

This is a form of manganese, an essential trace mineral, used as a nutritional supplement to prevent or treat manganese deficiency, often as a component of intravenous nutrition solutions in patients who cannot eat normally. Manganese is needed in very small amounts for bone formation, enzyme function, and metabolism. Excess manganese can accumulate in the brain and cause neurological symptoms, so it is used only under medical supervision.

Molecular Weight

151.0000 g/mol

TPSA

88.60 Ų

Mechanism of Action

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanism

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

SMILES

[O-]S(=O)(=O)[O-].[Mn+2]

InChI

InChI=1S/Mn.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2

Molecular Formula

MnO4S

HBD / HBA

- / 4

Rotatable Bonds

0

Heavy Atoms

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This is a form of manganese, an essential trace mineral, used as a nutritional supplement to prevent or treat manganese deficiency, often as a component of intravenous nutrition solutions in patients who cannot eat normally. Manganese is needed in very small amounts for bone formation, enzyme function, and metabolism. Excess manganese can accumulate in the brain and cause neurological symptoms, so it is used only under medical supervision.

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Yes, Manganese Sulfate Anhydrous is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200557. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24580. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.